The authors observed that the changes in miR-5196 serum expression levels after anti-TNFα therapy were positively correlated with decreased disease activity in both RA and AS patients, suggesting that levels of circulating miR-5196 might be useful for the prediction of anti-TNF therapeutic efficacy. Here, TNF is linked to rheumatoid arthritis.